InvestorsHub Logo
Followers 46
Posts 10977
Boards Moderated 0
Alias Born 02/14/2007

Re: None

Friday, 10/24/2014 1:23:44 PM

Friday, October 24, 2014 1:23:44 PM

Post# of 5006
Patent news...Moving forward

10/24/2014 09:24:58 AM ED


Alexandria, Oct. 24 -- RXI Pharmaceuticals has submitted a patent application for RNA interference in skin indications. Khvorova Anastasia, Salomon William, Kamens Joanne, Samarsky Dmitry, Woolf Tod M, Pavco Pamela A and Cardia James developed the invention.

The patent application number is 14/104450. International Patent Classification code is C12N 15/113 20060101 C12N015/113. Cooperative Patent Classification code is C12N 15/113 20130101.

U.S. Patent and Trademark Office has released the abstract. According to the abstract, "The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PHIO News